Clinical trial
Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
NCT06760650 is registered in ClinicalTrials.gov with Saint-Joseph University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
- Lead sponsor
- Saint-Joseph University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 7, 2025
- Completion date
- October 10, 2025
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, chronic kidney disease stage 3b, chronic kidney disease stage 4, chronic kidney disease stage 5, diabetes mellitus, fluorescein angiography